Skip to content
Terms & Conditions
AbbVie Signs an Exclusive Agreement with Scripps Research to Develop New Therapies Targeting Multiple Therapeutic Areas
Roche’s Accu-Chek SugarView App Receives CE Mark Approval for Non-Insulin-Dependent Patients with Type 2 Diabetes or Pre-Diabetes
AstraZeneca Collaborates with DeepMatter for Optimization of Compound Synthesis Leveraging AI and Machine Learning
Merck to Acquire ArQule for $2.7B
AstraZeneca Reports Results of Calquence (acalabrutinib) in P-III ELEVATE TN Study for Previously Untreated Chronic Lymphocytic Leukemia
Insights+ Key Biosimilars Events of November 2019
Top Biosimilar Companies with Approved and Pipeline Products in the US and EU
Subscribe To Our News Alerts
Join our mailing list to receive the latest news alerts from PharmaShots.
You are now subscribed to our NewsAlerts!